A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose

Clinical trial NCT07406334 · RECRUITING

Trial details

NCT number: NCT07406334
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumonia, Bacterial

Start date: 2026-05-15
Primary completion: 2027-02-22
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.